Share This Article:

Intracranial Atherosclerosis: The Natural History and Management Strategies

Abstract Full-Text HTML XML Download Download as PDF (Size:353KB) PP. 350-360
DOI: 10.4236/wjcd.2014.47044    2,888 Downloads   3,943 Views   Citations

ABSTRACT

Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Mansour, O. , Schumacher, M. , Farrag, M. and Abd-Allah, F. (2014) Intracranial Atherosclerosis: The Natural History and Management Strategies. World Journal of Cardiovascular Diseases, 4, 350-360. doi: 10.4236/wjcd.2014.47044.

References

[1] Taylor, T.N., Davis, P.H., Torner, J.C., Holmes, J., Meyer, J.W. and Jacobson, M.F. (1996) Lifetime Cost of Stroke in the United States. Stroke, 27, 1459-1466.
http://stroke.ahajournals.org/content/27/9/1459
[2] Wityk, R.J., Lehman, D., Klag, M., Coresh, J., Ahn, H. and Litt, B. (1996) Race and Sex Differences in the Distribution of Cerebral Atherosclerosis. Stroke, 27, 1974-1980.
http://stroke.ahajournals.org/content/27/11/1974
[3] White, H., Boden-Albala, B., Wang, C.L., Elkind, M.S.V., Rundek, T., Wright, C.B. and Sacco, R.L. (2005) Ischemic Stroke Subtype Incidence among Whites, Blacks, and Hispanics: The Northern Manhattan Study. Circulation, 111, 1327-1331.
http://dx.doi.org/10.1161/01.CIR.0000157736.19739.D0
[4] Qureshi, A.I., Feldmann, E., Gomez, C.R., Johnston, S.C., Kasner, S.E., Quick, D.C., Rasmussen, P.A., Fareed, M., Suri, K., Taylor, R.A. and Zaidat, O.O. (2009) Intracranial Atherosclerotic Disease: An Update. Annals of Neurology, 66, 730-738.
http://dx.doi.org/10.1002/ana.21768
[5] Chimowitz, M.I., Lynn, M.J., Howlett-Smith, H., Stern, B.J., Hertzberg, V.S., Frankel, M.R., Levine, S.R., Chaturvedi, S., Kasner, S.E., Benesch, C.G., Sila, C.A., Jovin, T.G. and Romano, J.G. (2005) Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. New England Journal of Medicine, 352, 1305-1316.
http://dx.doi.org/10.1056/NEJMoa043033
[6] Siddiq, F., Memon, M.Z., Vazquez, G., Safdar, A. and Qureshi, A.I. (2009) Comparison between Primary Angioplasty and Stent Placement for Symptomatic Intracranial Atherosclerotic Disease: Meta-Analysis of Case Series. Neurosurgery, 65, 1024.
http://dx.doi.org/10.1227/01.NEU.0000360138.54474.52
[7] Bose, A., Hartmann, M., Henkes, H., Liu, H.M., Teng, M.M.H., Szikora, I., Berlis, A., Reul, J., Yu, S.C.H., Forsting, M., Lui, M., Lim, W. and Sit, S.P. (2007) A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses. Stroke, 38, 1531-1537.
http://dx.doi.org/10.1161/STROKEAHA.106.477711
[8] Eberhardt, O., Naegele, T., Raygrotzki, S., Weller, M. and Ernemann, U. (2006) Stenting of Vertebrobasilar Arteries in Symptomatic Atherosclerotic Disease and Acute Occlusion: Case Series and Review of the Literature. Journal of Vascular Surgery, 43, 1145-1154.
http://dx.doi.org/10.1016/j.jvs.2006.02.027
[9] Akins, P.T., Pilgram, T.K., Cross III, DeWitte T. and Moran, C.J. (1998) Natural History of Stenosis from Intracranial Atherosclerosis by Serial Angiography. Stroke, 29, 433-438.
http://dx.doi.org/10.1161/01.STR.29.2.433
[10] Kwon, S.U., Cho, Y.-J., Koo, J.-S., Bae, H.-J., Lee, Y.-S., Hong, K.-S., Lee, J.H. and Kim, J.S. (2005) Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis. Stroke, 36, 782-786.
http://dx.doi.org/10.1161/01.STR.0000157667.06542.b7
[11] Lee, Y.S., Bae, H.-J., Kang, D.-W., Lee, S.-H., Yu, K., Park, J.-M., Cho, Y.-J., Hong, K.-S., Kim, D.-E., Kwon, S.U., Lee, K.B., Rha, J.-H., Koo, J., Han, M.-G., Lee, S.J., Lee, J.-H., Jung, S.W., Lee, B.-C. and Kim, J.S. (2011) Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial. Cerebrovascular Diseases, 32, 65-71.
http://dx.doi.org/10.1159/000327036
[12] Kasner, S.E., Chimowitz, M.I., Lynn, M.J., Howlett-Smith, H., Stern, B.J., Hertzberg, V.S., Frankel, M.R., Levine, S.R., Chaturvedi, S., Benesch, C.G., Sila, C.A., Jovin, T.G., Romano, J.G. and Cloft, H.J. (2006) Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis. Circulation, 113, 555-563.
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.578229
[13] Mazighi, M., Tanasescu, R., Ducrocq, X., Vicaut, E., Bracard, S., Houdart, E. and Woimant, F. (2006) Prospective Study of Symptomatic Atherothrombotic Intracranial Stenoses. Neurology, 66, 1187-1191.
http://dx.doi.org/10.1212/01.wnl.0000208404.94585.b2
[14] Liebeskind, D.S., Cotsonis, G.A., Saver, J.L., Lynn, M.J., Cloft, H.J. and Chimowitz, M.I. (2011) Collateral Circulation in Symptomatic Intracranial Atherosclerosis. Journal of Cerebral Blood Flow & Metabolism, 31, 1293-1301.
http://dx.doi.org/10.1038/jcbfm.2010.224
[15] Wong, K.S., Gao, S., Chan, Y.L., Hansberg, T., Lam, W.W.M., Droste, D.W., Kay, R. and Ringelstein, E.B. (2002) Mechanisms of Acute Cerebral Infarctions in Patients with Middle Cerebral Artery Stenosis: A Diffusion-Weighted Imaging and Microemboli Monitoring Study. Annals of Neurology, 52, 74-81.
http://dx.doi.org/10.1002/ana.10250
[16] Del Sette, M., Eliasziw, M., Streifler, J.Y., Hachinski, V.C., Fox, A.J. and Barnett, H.J. (2000) Internal Borderzone Infarction: A Marker for Severe Stenosis in Patients with Symptomatic Internal Carotid Artery Disease. For the North American Symptomatic Carotid Endarterectomy (NASCET) Group. Stroke, 31, 631-636.
http://dx.doi.org/10.1161/01.STR.31.3.631
[17] Caplan, L.R. (1989) Intracranial Branch Atheromatous Disease A Neglected, Understudied, and Underused Concept. Neurology, 39, 1246-1246.
http://www.neurology.org/content/39/9/1246.
[18] Derdeyn, C.P., Grubb, R.L. and Powers, W.J. (1999) Cerebral Hemodynamic Impairment, Methods of Measurement and Association with Stroke Risk. Neurology, 53, 251-251.
http://www.neurology.org/content/53/2/251.
[19] Yamauchi, H., Nishii, R., Higashi, T., Kagawa, S. and Fukuyama, H. (2009) Hemodynamic Compromise as a Cause of Internal Border-Zone Infarction and Cortical Neuronal Damage in Atherosclerotic Middle Cerebral Artery Disease. Stroke, 40, 3730-3735.
http://dx.doi.org/10.1161/STROKEAHA.109.560011
[20] Naritomi, H., Sawada, T., Kuriyama, Y., Kinugawa, H., Kaneko, T. and Takamiya, M. (1985) Effect of Chronic Middle Cerebral Artery Stenosis on the Local Cerebral Hemodynamics. Stroke, 16, 214-219.
http://dx.doi.org/10.1161/01.STR.16.2.214
[21] Kim, Y.D., Cha, M.J., Kim, J., Lee, D.H., Lee, H.S., Nam, C.M., et al. (2011) Increases in Cerebral Atherosclerosis According to CHADS2 Scores in Patients with Stroke with Nonvalvular Atrial Fibrillation. Stroke, 42, 930-934.
http://dx.doi.org/10.1161/STROKEAHA.110.602987
[22] Lee, D.K., Kim, J.S., Kwon, S.U., Yoo, S.H. and Kang, D.W. (2005) Lesion Patterns and Stroke Mechanism in Atherosclerotic Middle Cerebral Artery Disease: Early Diffusion-Weighted Imaging Study. Stroke, 36, 2583-2588.
http://dx.doi.org/10.1161/01.STR.0000189999.19948.14
[23] Pico, F., Labreuche, J., Cohen, A., Touboul, P.J. and Amarenco, P. (2004) Intracranial Arterial Dolichoectasia Is Associated with Enlarged Descending Thoracic Aorta. Neurology, 63, 2016-2021.
http://dx.doi.org/10.1212/01.WNL.0000145845.12577.0F
[24] Smoker, W.R., Price, M.J., Keyes, W.D., Corbett, J.J. and Gentry, L.R. (1986) High-Resolution Computed Tomography of the Basilar Artery: 1. Normal Size and Position. American Journal of Neuroradiology, 7, 55-60.
[25] Hennerici, M., Rautenberg, W., Sitzer, G. and Schwartz, A. (1987) Transcranial Doppler Ultrasound for the Assessment of Intracranial Arterial Flow Velocity—Part 1. Examination Technique and Normal Values. Surgical Neurology, 27, 439-448.
http://dx.doi.org/10.1016/0090-3019(87)90251-5
[26] Caplan, L.R. (2005) Dilatative Arteriopathy (Dolichoectasia): What Is Known and Not Known. Annals of Neurology, 57, 469-471.
http://dx.doi.org/10.1002/ana.20447
[27] He, J., Whelton, P.K., Vu, B. and Klag, M.J. (1998) Aspirin and Risk of Hemorrhagic Stroke: A Meta-Analysis of Randomized Controlled Trials. JAMA, 280, 1930-1935.
http://dx.doi.org/10.1001/jama.280.22.1930
[28] Alazzaz, A., Thornton, J., Aletich, V.A., Debrun, G.M., Ausman, J.I. and Charbel, F. (2000) Intracranial Percutaneous Transluminal Angioplasty for Arteriosclerotic Stenosis. Archives of Neurology, 57, 1625-1630.
http://archneur.ama-assn.org/cgi/content/abstract/57/11/1625
[29] Connors 3rd, J.J. and Wojak, J.C. (1999) Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Lesions: Evolution of Technique and Short-Term Results. Journal of Neurosurgery, 91, 415-423.
http://www.ncbi.nlm.nih.gov/pubmed/10470816
[30] Fiorella, D., Masaryk, T.J. and Turk, A.S. (2010) Technical Aspects of Intracranial Angioplasty and Stenting. Cerebral Revascularization: Microsurgical and Endovascular Techniques.
[31] Yu, S.C., Leung, T.W., Hung, E.H., Lee, K.T. and Wong, L.K. (2012) Angioplasty and Stenting for Intracranial Atherosclerotic Stenosis with Nitinol Stent: Factors Affecting Technical Success and Patient Safety. Neurosurgery, 70, ons104-ons113.
http://dx.doi.org/10.1227/NEU.0b013e3182320bb0
[32] Zhao, Z.W., Deng, J.P., He, S.M., Qin, H.Z., Gao, L. and Gao, G.D. (2009) Intracranial Angioplasty with Gateway-Wingspan System for Symptomatic Atherosclerotic Stenosis: Preliminary Results of 27 Chinese Patients. Surgical Neurology, 72, 607-611.
http://dx.doi.org/10.1016/j.surneu.2009.06.017
[33] Sundt Jr., T.M., Smith, H.C., Campbell, J.K., Vlietstra, R.E., Cucchiara, R.F., Stanson, A.W. (1980) Transluminal Angioplasty for Basilar Artery Stenosis. Mayo Clinic Proceedings, 55, 673-680.
[34] Callahan 3rd, A.S. and Berger, B.L. (1997) Balloon Angioplasty of Intracranial Arteries for Stroke Prevention. Journal of Neuroimaging, 7, 232-235.
[35] Marks, M.P., Marcellus, M., Norbash, A.M., Steinberg, G.K., Tong, D. and Albers, G.W. (1999) Outcome of Angioplasty for Atherosclerotic Intracranial Stenosis. Stroke, 30, 1065-1069.
http://stroke.ahajournals.org/content/30/5/1065
[36] Connors 3rd, J.J. and Wojak, J.C. (1999) Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Lesions: Evolution of Technique and Short-Term Results. Journal of Neurosurgery, 91, 415-423.
http://dx.doi.org/10.3171/jns.1999.91.3.0415
[37] Nahser, H.C., Henkes, H., Weber, W., Berg-Dammer, E., Yousry, T.A. and Kühne, D. (2000) Intracranial Vertebrobasilar Stenosis: Angioplasty and Follow-Up. American Journal of Neuroradiology, 21, 1293-1301.
[38] Marks, M.P., Marcellus, M.L., Do, H.M., Schraedley-Desmond, P.K., Steinberg, G.K., Tong, D.C., et al. (2005) Intracranial Angioplasty without Stenting for Symptomatic Atherosclerotic Stenosis: Long-Term Follow-Up. American Journal of Neuroradiology, 26, 525-530.
http://www.ajnr.org/content/26/3/525
[39] Qureshi, A.I. (2012) Interpretation and Implications of the Prematurely Terminated Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in the Intracranial Stenosis (SAMMPRIS) Trial. Neurosurgery, 70, E264-E268.
http://dx.doi.org/10.1227/NEU.0b013e318239f318
[40] Tarr, R.W., Albuquerque, F., Hirsh, J. and Prestigiacomo, C. (2011) The SAMMPRIS Trial: The End or Just the Beginning. Journal of Neurointerventional Surgery, 3, 310-311.
http://dx.doi.org/10.1136/neurintsurg-2011-010144
[41] Mori, T., et al. (1997) Percutaneous Transluminal Cerebral Angioplasty: Serial Angiographic Follow-Up after Successful Dilatation. Neuroradiology, 39, 111-116.
[42] Powers, W.J., Clarke, W.R., Grubb Jr., R.L., Videen, T.O., Adams Jr., H.P., Derdeyn, C.P. (2011) Extracranial-Intra-cranial Bypass Surgery for Stroke Prevention in Hemodynamic Cerebral Ischemia: The Carotid Occlusion Surgery Study Randomized Trial. JAMA, 306, 1983-1992.
http://dx.doi.org/10.1001/jama.2011.1610
[43] Platform, I.C.T.R. (2012) Early Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis (ESASIS).
[44] Derdeyn, C.P., Videen, T.O., Simmons, N.R., Yundt, K.D., Fritsch, S.M., Grubb Jr., R.L., et al. (1999) Count-Based PET Method for Predicting Ischemic Stroke in Patients with Symptomatic Carotid Arterial Occlusion. Radiology, 212, 499-506.
[45] Dorros, G., Cohn, J.M. and Palmer, L.E. (1998) Stent Deployment Resolves a Petrous Carotid Artery Angioplasty Dissection. American Journal of Neuroradiology, 19, 392-394.
[46] Phatouros, C.C., Higashida, R.T., Malek, A.M., Smith, W.S., Mully, T.W., DeArmond, S.J., et al. (1999) Endovascular Stenting of an Acutely Thrombosed Basilar Artery: Technical Case Report and Review of the Literature. Neurosurgery, 44, 667-673.
http://dx.doi.org/10.1097/00006123-199903000-00134
[47] Morris, P.P., Martin, E.M., Regan, J. and Braden, G. (1999) Intracranial Deployment of Coronary Stents for Symptomatic Atherosclerotic Disease. American Journal of Neuroradiology, 20, 1688-1694.
[48] Yu, W., Smith, W.S., Singh, V., Ko, N.U., Cullen, S.P. and Dowd, C.F. (2005) Long-Term Outcome of Endovascular Stenting for Symptomatic Basilar Artery Stenosis. Neurology, 64, 1055-1057.
http://www.neurology.org/content/64/6/1055
[49] Gomez, C.R., Misra, V.K., Liu, M.W., Wadlington, V.R., Terry, J.B. and Tulyapronchote, R. (2000) Elective Stenting of Symptomatic Basilar Artery Stenosis. Stroke, 31, 95-99.
http://stroke.ahajournals.org/content/31/1/95
[50] Mazighi, M., Yadav, J.S. and Abou-Chebl, A. (2008) Durability of Endovascular Therapy for Symptomatic Intracranial Atherosclerosis. Stroke, 39, 1766-1769.
http://dx.doi.org/10.1161/STROKEAHA.107.500587
[51] SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA) Study Results. Stroke, 35, 1388-1392.
http://dx.doi.org/10.1161/01.STR.0000128708.86762.d6
[52] Lutsep, H.L. (2009) Symptomatic Intracranial Stenosis: Best Medical Treatment vs. Intracranial Stenting. Current Opinion in Neurology, 22, 69-74.
http://dx.doi.org/10.1097/WCO.0b013e32831504e4
[53] Steinfort, B., Ng, P.P., Faulder, K., Harrington, T., Grinnell, V., Sorby, W., et al. (2007) Midterm Outcomes of Paclitaxel-Eluting Stents for the Treatment of Intracranial Posterior Circulation Stenoses. Journal of Neurosurgery, 106, 222-225.
http://dx.doi.org/10.3171/jns.2007.106.2.222
[54] Qureshi, A.I., Kirmani, J.F., Hussein, H.M., Harris-Lane, P., Divani, A.A., Suri, M.F., et al. (2006) Early and Intermediate-Term Outcomes with Drug-Eluting Stents in High-Risk Patients with Symptomatic Intracranial Stenosis. Neurosurgery, 59, 1044-1051.
[55] Abou-Chebl, A., Bashir, Q. and Yadav, J.S. (2005) Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-Up. Stroke, 36, e165-e168.
http://dx.doi.org/10.1161/01.STR.0000190893.74268.fd
[56] Gupta, R., Al-Ali, F., Thomas, A.J., Horowitz, M.B., Barrow, T., Vora, N.A., et al. (2006) Safety, Feasibility, and Short-Term Follow-Up of Drug-Eluting Stent Placement in the Intracranial and Extracranial Circulation. Stroke, 37, 2562-2566.
http://dx.doi.org/10.1161/01.STR.0000242481.38262.7b
[57] Natarajan, S.K., Ogilvy, C.S., Hopkins, L.N., Siddiqui, A.H. and Levy, E.I. (2010) Initial Experience with an Everolimus-Eluting, Second-Generation Drug-Eluting Stent for Treatment of Intracranial Atherosclerosis. Journal of NeuroInterventional Surgery, 2, 104-109.
http://dx.doi.org/10.1136/jnis.2009.001875
[58] Rahme, R.J., Aoun, S.G., Batjer, H.H. and Bendok, B.R. (2011) SAMMPRIS: End of Intracranial Stenting for Atherosclerosis or Back to the Drawing Board? Neurosurgery, 69, N16-N18.
http://dx.doi.org/10.1227/01.neu.0000407920.96189.cc
[59] Benesch, C.G. and Chimowitz, M.I. (2000) Best Treatment for Intracranial Arterial Stenosis? Neurology, 55, 465-466.
http://dx.doi.org/10.1212/WNL.55.4.465
[60] Fiorella, D.J., Turk, A.S., Levy, E.I., Pride Jr., G.L., Woo, H.H., Albuquerque, F.C., et al. (2011) US Wingspan Registry. Stroke, 42, 1976-1981.
http://dx.doi.org/10.1161/STROKEAHA.111.613877
[61] Jiang, W.J., Cheng-Ching, E., Abou-Chebl, A., Zaidat, O.O., Jovin, T.G., Kalia, J., et al. (2012) Multicenter Analysis of Stenting in Symptomatic Intracranial Atherosclerosis. Neurosurgery, 70, 25-31.
http://dx.doi.org/10.1227/NEU.0b013e31822d274d
[62] Higashida, R.T., Tsai, F.Y., Halbach, V.V., Dowd, C.F., Smith, T., Fraser, K., et al. (1993) Transluminal Angioplasty for Atherosclerotic Disease of the Vertebral and Basilar Arteries. Journal of Neurosurgery, 78, 192-198.
http://dx.doi.org/10.3171/jns.1993.78.2.0192
[63] Terada, T., Higashida, R.T., Halbach, V.V., Dowd, C.F., Nakai, E., Yokote, H., et al. (1996) Transluminal Angioplasty for Arteriosclerotic Disease of the Distal Vertebral and Basilar Arteries. Journal of Neurology, Neurosurgery & Psychiatry, 60, 377-381.
http://dx.doi.org/10.1136/jnnp.60.4.377
[64] Takis, C., Kwan, E.S., Pessin, M.S., Jacobs, D.H. and Caplan, L.R. (1997) Intracranial Angioplasty: Experience and Complications. American Journal of Neuroradiology, 18, 1661-1668.
[65] Grubb, R.L., Derdeyn, C.P., Fritsch, S.M., Carpenter, D.A., Yundt, K.D., Videen, T.O., et al. (1998) Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion. JAMA: The Journal of the American Medical Association, 280, 1055-1060.
http://dx.doi.org/10.1001/jama.280.12.1055
[66] Carlson, A.P., Yonas, H., Chang, Y.F. and Nemoto, E.M. (2011) Failure of Cerebral Hemodynamic Selection in General or of Specific Positron Emission Tomography Methodology? Carotid Occlusion Surgery Study (COSS). Stroke, 42, 3637-3639.
http://dx.doi.org/10.1161/STROKEAHA.111.627745
[67] (1985) Failure of Extracranial-Intracranial Arterial Bypass to Reduce the Risk of Ischemic Stroke. Results of an International Randomized Trial. The EC/IC Bypass Study Group. The New England Journal of Medicine, 313, 1191-200.
http://dx.doi.org/10.1056/NEJM198511073131904
[68] Powers, W.J. (2012) Letter by Powers Regarding Article, “Failure of Cerebral Hemodynamic Selection in General or of Specific Positron Emission Tomography Methodology? Carotid Occlusion Surgery Study (COSS)”. Stroke, 43, e43. http://dx.doi.org/10.1161/STROKEAHA.111.648097

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.